Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ao-176 (2 trials)
bortezomib (velcade) (1 trial)
dexamethasone (1 trial)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Trials (2 total)
Trial APIs (3 total)